Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

reddit: 1 Redditor

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application

Article in Frontiers in Immunology (May 2024)

PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer

Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (May 2024)

Hypoxia-induced OSBPL10 accelerates pancreatic cancer progression through CNBP sequestration

Preprint in Research Square (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.